Bristol Liabilities And Stockholders Equity from 2010 to 2025

BMY Stock  USD 43.83  0.56  1.26%   
Bristol Myers Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity is likely to outpace its year average in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Bristol Myers' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
1987-12-31
Previous Quarter
92.4 B
Current Value
94.7 B
Quarterly Volatility
31.6 B
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.1 B, Interest Expense of 2 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0378 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.